Taichung Veterans General Hospital Wins TriNetX Outstanding Partner Award, First in Asia
Taichung Veterans General Hospital (TCVGH) has received the "2026 Outstanding Partner Award" from the international medical research data platform TriNetX, making it the first medical institution in Asia to achieve this honor. This award recognizes TCVGH's achievements in smart healthcare and clinical research.
📋 Article Processing Timeline
- 📰 Published: April 28, 2026 at 12:16
- 🔍 Collected: April 28, 2026 at 12:31 (15 min after Published)
- 🤖 AI Analyzed: April 28, 2026 at 13:16 (44 min after Collected)
Central News Agency
(Central News Agency reporter Hao Xueqing, Taichung, 28th) Taichung Veterans General Hospital (TCVGH) announced today that it has been selected by the international medical research data platform TriNetX as a recipient of the "2026 Outstanding Partner Award," becoming the first medical institution in Asia to receive this honor. This award recognizes TCVGH's achievements in smart healthcare, clinical practice, and other aspects.
TCVGH explained through a press release that TriNetX is a globally renowned medical research data platform that integrates de-identified patient medical record data from over 10,000 medical institutions and 300 million patients worldwide. It assists researchers in building accurate data cohorts and conducting real-time queries and advanced analyses.
Each quarter, TriNetX selects one outstanding medical institution from its global partner hospitals based on multiple indicators such as data quality, data volume, research performance, and regulatory compliance, to present the "Outstanding Partner Award." Given the platform's extensive application in clinical research, evidence-based medicine, and new drug development, receiving this award holds significant international symbolic meaning.
TCVGH stated that it recently received the "2026 Outstanding Partner Award" from TriNetX, becoming the first medical institution in Asia to receive this honor. This acknowledges TCVGH's achievements in utilizing clinical data to promote research in smart healthcare, clinical practice, and database management and application. The Senior Vice President of Global Medical Partnerships at TriNetX recently visited TCVGH in Taiwan to present the award, which was accepted by TCVGH Superintendent Fu Yun-ching on behalf of the hospital.
TCVGH pointed out that by introducing TriNetX as the core platform for its data-driven research, it has successfully connected clinical practice with research and development. This not only shortens the time from research design to data validation but also enhances the credibility of research outcomes, further strengthening the foundation of evidence-based medicine.
TCVGH explained that these achievements help transform Taiwan's clinical experience into evidence-based findings with international influence. In the future, TCVGH will continue to deepen digital medical development, strengthen international research cooperation, and combine clinical, technological, and research capabilities to provide the public with more precise, safe, and forward-looking medical services. (Editor: Zhang Mingkun) 1150428
(Central News Agency reporter Hao Xueqing, Taichung, 28th) Taichung Veterans General Hospital (TCVGH) announced today that it has been selected by the international medical research data platform TriNetX as a recipient of the "2026 Outstanding Partner Award," becoming the first medical institution in Asia to receive this honor. This award recognizes TCVGH's achievements in smart healthcare, clinical practice, and other aspects.
TCVGH explained through a press release that TriNetX is a globally renowned medical research data platform that integrates de-identified patient medical record data from over 10,000 medical institutions and 300 million patients worldwide. It assists researchers in building accurate data cohorts and conducting real-time queries and advanced analyses.
Each quarter, TriNetX selects one outstanding medical institution from its global partner hospitals based on multiple indicators such as data quality, data volume, research performance, and regulatory compliance, to present the "Outstanding Partner Award." Given the platform's extensive application in clinical research, evidence-based medicine, and new drug development, receiving this award holds significant international symbolic meaning.
TCVGH stated that it recently received the "2026 Outstanding Partner Award" from TriNetX, becoming the first medical institution in Asia to receive this honor. This acknowledges TCVGH's achievements in utilizing clinical data to promote research in smart healthcare, clinical practice, and database management and application. The Senior Vice President of Global Medical Partnerships at TriNetX recently visited TCVGH in Taiwan to present the award, which was accepted by TCVGH Superintendent Fu Yun-ching on behalf of the hospital.
TCVGH pointed out that by introducing TriNetX as the core platform for its data-driven research, it has successfully connected clinical practice with research and development. This not only shortens the time from research design to data validation but also enhances the credibility of research outcomes, further strengthening the foundation of evidence-based medicine.
TCVGH explained that these achievements help transform Taiwan's clinical experience into evidence-based findings with international influence. In the future, TCVGH will continue to deepen digital medical development, strengthen international research cooperation, and combine clinical, technological, and research capabilities to provide the public with more precise, safe, and forward-looking medical services. (Editor: Zhang Mingkun) 1150428